Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 8-K Event Agreement ended · Exit or restructuring costs
  2. 8-K Event Regulation FD disclosure · Other events
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations · Regulation FD disclosure
  5. 8-K Event Regulation FD disclosure
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations · Regulation FD disclosure
  8. 8-K Event Regulation FD disclosure · Other events
  9. 8-K Event Shareholder vote results
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations · Regulation FD disclosure
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations · Regulation FD disclosure
  14. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  15. 8-K Event Regulation FD disclosure
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. 8-K Event Executive or director change · Regulation FD disclosure
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 1 of 4 · 79 filings